Literature DB >> 31767933

A novel POC1A variant in an alternatively spliced exon causes classic SOFT syndrome: clinical presentation of seven patients.

Adila Al-Kindi1, Maryam Al-Shehhi2, Ana Westenberger3,4, Christian Beetz4, Patrick Scott1,5, Oliver Brandau4,6, Lia Abbasi-Moheb4, Zafer Yüksel4, Peter Bauer4, Arndt Rolfs4,7, Nana-Maria Grüning8.   

Abstract

Biallelic pathogenic variants in POC1A are ultra rare. They have been reported in 13 families as causing either Short stature, Onychodysplasia, Facial dysmorphism, and hypoTrichosis (SOFT) syndrome, or a milder partially overlapping phenotype, variant POC1A-related syndrome. This pleiotropic effect is likely precipitated by the variant's location and respective affected protein domain. Here, we describe seven patients from two consanguineous Omani families with classic SOFT syndrome and a novel homozygous POC1A variant (c.64G>T; p.(Val22Phe)), which is the first one described for the alternative exon 2. This result refines the POC1A mutational spectrum relevant for exertion of the described pleiotropic effect. Furthermore, six of our patients experienced recurrent mild to severe respiratory difficulties that have not been previously reported for SOFT syndrome and may be an underdiagnosed or a genotype-specific complication that warrants attention in future studies. Thus, our study unravels new aspects of the genotype-phenotype correlation suggested by previous reports.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31767933     DOI: 10.1038/s10038-019-0693-2

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  1 in total

1.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

  1 in total
  3 in total

1.  Identification of SOFT syndrome caused by a pathogenic homozygous splicing variant of POC1A: a case report.

Authors:  Guoqiang Li; Guoying Chang; Chen Wang; Tingting Yu; Niu Li; Xiaodong Huang; Xiumin Wang; Jian Wang; Jiwen Wang; Ruen Yao
Journal:  BMC Med Genomics       Date:  2021-08-21       Impact factor: 3.063

2.  Further phenotypic features and two novel POC1A variants in a patient with SOFT syndrome: A case report.

Authors:  Songting Li; Yan Zhong; Yongjia Yang; Siping He; Wenjuan He
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

3.  Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps.

Authors:  Veronica Mericq; Isabel Huang-Doran; Dhekra Al-Naqeb; Javiera Basaure; Claudia Castiglioni; Christiaan de Bruin; Yvonne Hendriks; Enrico Bertini; Fowzan S Alkuraya; Monique Losekoot; Khalid Al-Rubeaan; Robert K Semple; Jan M Wit
Journal:  Eur J Endocrinol       Date:  2022-03-23       Impact factor: 6.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.